INS and Obesity: Given that GPR55 activation reduces glucose levels, stimulates insulin secretion from pancreatic β cells, promotes insulin signalling in myotubes, and contributes to manifestation of obesity and diabetes, the receptor could also impact on the metabolically imbalanced myocardium upon ischaemic injury20,21,44.